文献速递糖尿病

PedsQL 3.2 糖尿病模块在儿童、青少年和年轻成人1型糖尿病中的信效度

PedsQL 3.2 Diabetes Module for Children, Adolescents, and Young Adults: Reliability and Validity in Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2018-07-30

该研究基于10个中心656个1型糖尿病家庭的现场测试,评估修订版PedsQL 3.2糖尿病模块的测量性能。因子分析得出15项糖尿病症状总结分和18项糖尿病管理总结分,信度优秀(患者自评α=0.88-0.90,家长代理α=0.89-0.90),与通用核心量表总分中至大效应相关(r=0.43-0.67,P<0.001),HbA1c与两总结分显著相关(r=-0.21至-0.29,P<0.001),最小临床重要差异为5.05至5.55。

要点

  • 糖尿病症状与管理总结分信度优秀,患者自评α=0.88-0.90,家长代理α=0.89-0.90。
  • 两总结分与通用核心量表总分呈中至大效应相关(r=0.43-0.67,P<0.001)。
  • HbA1c与两总结分显著负相关(r=-0.21至-0.29,P<0.001),最小临床重要差异5.05-5.55。

核心结论

  • PedsQL 3.2糖尿病模块的症状与管理总结分具有优秀的测量性能,可能作为1型糖尿病儿童、青少年和年轻成人症状与管理的标准化患者报告结局用于临床研究、临床试验和实践。

研究设计与样本

  • 10个中心全国现场测试研究,由656个2-25岁1型糖尿病患者的家庭完成33项PedsQL 3.2糖尿病模块和PedsQL通用核心量表。

主要发现

  • 因子分析得出15项糖尿病症状总结分和18项糖尿病管理总结分。
  • 症状与管理总结分信度优秀:患者自评α=0.88-0.90,家长代理α=0.89-0.90。
  • 两总结分与通用核心量表总分呈中至大效应相关(r=0.43-0.67,P<0.001)。
  • HbA1c与症状和管理总结分显著相关(r=-0.21至-0.29,P<0.001)。
  • 最小临床重要差异范围为5.05至5.55。

关键数值与推荐

  • 糖尿病症状总结分15项,糖尿病管理总结分18项。
  • 患者自评α=0.88-0.90,家长代理α=0.89-0.90。
  • 与通用核心量表总分相关r=0.43-0.67,P<0.001。
  • HbA1c相关r=-0.21至-0.29,P<0.001。
  • 最小临床重要差异5.05至5.55。

临床怎么用

  • 该模块可能作为1型糖尿病儿童、青少年和年轻成人症状与管理的标准化患者报告结局用于临床研究、临床试验和实践。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of the study was to report on the measurement properties of the revised and updated Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for children, adolescents, and young adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: The 33-item PedsQL 3.2 Diabetes Module and PedsQL Generic Core Scales were completed in a 10-site national field test study by 656 families of patients ages 2-25 years with type 1 diabetes. RESULTS: The 15-item Diabetes Symptoms Summary Score and 18-item Diabetes Management Summary Score were derived from the factor analysis of the items. The Diabetes Symptoms and Diabetes Management Summary Scores evidenced excellent reliability (patient self-report α = 0.88-0.90; parent proxy report α = 0.89-0.90). The Diabetes Symptoms and Diabetes Management Summary Scores demonstrated construct validity through medium to large effect size correlations with the Generic Core Scales Total Scale Score (r = 0.43-0.67, P < 0.001). HbA1c was significantly correlated with the Diabetes Symptoms and Diabetes Management Summary Scores (r = -0.21 to -0.29, P < 0.001). Minimal clinically important difference scores ranged from 5.05 to 5.55. CONCLUSIONS: The PedsQL 3.2 Diabetes Module Diabetes Symptoms and Diabetes Management Summary Scores demonstrated excellent measurement properties and may be useful as standardized patient-reported outcomes of diabetes symptoms and diabetes management in clinical research, clinical trials, and practice in children, adolescents, and young adults with type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Varni JW, Delamater AM, Hood KK, et al. PedsQL 3.2 Diabetes Module for Children, Adolescents, and Young Adults: Reliability and Validity in Type 1 Diabetes. Diabetes Care. 2018. PMID: 30061317. doi:10.2337/dc17-2707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。